EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›KVAC

KVAC

Keen Vision Acquisition Corp.

Next earnings Aug 10, 2026

Avoid
$12.32▲ +8.83%
over 1Y
L $11.32EODHDH $12.46
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W+1.0%
1M+1.0%
3M+2.7%
YTD+4.9%
1Y+8.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Short (<3mo)
12-mo target
$•••

Expired blank-check SPAC trading 19% above its trust value with no deal and going-concern doubt — pay $12.32 to maybe get $10 back.

Price $12.32 · current

KVAC is not an operating business — it is a British Virgin Islands blank-check (SPAC) shell with no revenue in any year, incorporated in 2021 to find an acquisition it still has not found. The MD&A is explicit: 'We have not selected any specific business combination target and we have not... initiated any substantive discussions... with any business combination target.' The reported 'net income' ($1.91M FY2025, down 74% YoY) is not earnings — it is essentially trust-account interest and warrant/fair-value mark-to-market, not a sign of business quality. Stockholders' equity is negative (-$7.01M) and operating cash flow is negative (-$784K); the company runs on a near-empty operating account of just $11,206 in cash. The filing itself states 'These conditions raise substantial doubt about the Company's ability to continue as a going concern.'

The decisive fact is the clock. The 10-K states that if a combination is not consummated by April 27, 2026, the Company 'will... redeem 100% of the Company's outstanding public shares for a pro rata portion of the funds held in the Trust Account... and then seek to liquidate and dissolve.' Today is June 30, 2026 — that deadline has passed with no announced target, deal, or further extension in the provided data. The terminal value of a public share is therefore the trust pro-rata, roughly $57.0M trust ÷ 5.51M shares ≈ $10.34, and the filing warns warrants 'will expire and will be worthless.' The 49% YoY drop in shares outstanding and 19% drop in total assets show redemptions are already underway, consistent with a wind-down rather than a deal.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25
Revenue————
Gross profit————
Operating income————
Net income-$693.00$1.45M$7.41M$1.91M
Diluted EPS————
Net margin————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash$11.2K
Piotroski F-Score2/6

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-49.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 10-Q Quarterly report2026-05-08

    Q1'26 10-Q: going-concern doubt, no target, trust ~$57M as deadline arrives

  2. 8-K Material agreement2026-04-27

    Extended business-combination deadline again via sponsor loan deposited into trust

  3. 8-K Material agreement2026-04-15

    Entered new material definitive agreement just before the April 27 deadline

  4. 10-K Annual report2026-03-25

    FY25 10-K: net income -74%, going-concern doubt, no target, trust down to $57M

  5. 8-K Material agreement2026-03-02

    Signed material agreement (likely non-redemption/extension support)

  6. 8-K Material agreement2026-01-26

    Shareholders approved charter extension of merger deadline; redemptions cut trust

  7. 8-K Material agreement2026-01-05

    Proxy seeking shareholder vote to extend the business-combination deadline

  8. DEF 14A Proxy statement2026-01-05

    Proxy seeking shareholder vote to extend the business-combination deadline

  9. 8-K Material agreement2025-11-24

    New sponsor loan creates debt obligation to keep funding deal search

Recent filings

all on EDGAR ↗
PRE 14APeriod ending 2026-06-222026-06-22open ↗SCHEDULE 13G/AFiling2026-05-14open ↗10-QPeriod ending 2026-03-312026-05-08open ↗8-KPeriod ending 2026-04-212026-04-27open ↗8-KPeriod ending 2026-02-262026-04-15open ↗10-KPeriod ending 2025-12-312026-03-25open ↗8-KPeriod ending 2026-02-262026-03-02open ↗SCHEDULE 13G/AFiling2026-02-06open ↗8-KPeriod ending 2026-01-222026-01-26open ↗DEFA14AFiling2026-01-07open ↗DEF 14APeriod ending 2026-01-222026-01-05open ↗8-KPeriod ending 2025-12-192026-01-05open ↗

Quality score

F
ValueGrowthProfitHealthMom.
Value—
GrowthF
Profitability—
Financial healthF
Momentum—
  • ✓Profitable (positive net income)
  • ✓Liabilities below 2× equity
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals · FY 2025

'22'23'24'25

■ revenue · ■ net income, by fiscal year

Net income$1.91M-74.2%
Cash & equivalents$11.2K-79.5%
Total assets$57.0M-19.0%
Total liabilities$7.05M+65.3%
Stockholders' equity-$7.01M-67.0%
L/E: -1.01x

Frequently asked

Is Keen Vision Acquisition Corp. (KVAC) a buy?
KVAC currently carries a Avoid rating with 5/5 conviction, derived from its latest SEC filings. Expired blank-check SPAC trading 19% above its trust value with no deal and going-concern doubt — pay $12.32 to maybe get $10 back.
What is Keen Vision Acquisition Corp.'s quality score?
KVAC scores 27.333333333333332/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001889983, latest 10-Q filed 2026-05-08) · analysis by claude-code · as of 6/30/2026, 1:02:24 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Vs tracked universe

compare →

1192 tracked peers · median

EDGAR Score27 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 25.7